The effect of GIH and Boots secretin and cholecystokinin on duodenal ulcers in the rat.
The effects of two commercially available preparations of secretin and cholecystokinin have been studied on experimental duodenal ulcers in the rat. Pentagastrin and carbachol infused subcutaneously over 24 hours produced a 100% incidence of duodenal ulcers. A dose-related inhibition of these ulcers was found using secretin obtained from the Gastrointestinal Hormone Laboratory, Stockholm (GIH). Boots secretin had no such inhibitory action and may even have aggravated the duodenal ulcerogenesis. Similar results were obtained with both GIH cholecystokinin and Boots pancreozymin.
D000818:Animals; D002766:Cholecystokinin / Q000627:therapeutic use*; D004381:Duodenal Ulcer / Q000188:drug therapy* / Q000517:prevention & control; D005768:Gastrointestinal Hormones / Q000627:therapeutic use*; D008297:Male; D051381:Rats; D012633:Secretin / Q000627:therapeutic use*
D005768:Gastrointestinal Hormones; D012633:Secretin; D002766:Cholecystokinin